Anagenics Continues Talks With ASX to Lift Trading Suspension

MT Newswires Live

01-06

Anagenics (ASX:AN1) said it is in ongoing discussions with the Australian Securities Exchange to lift the suspension on the trading of its securities, according to a Friday filing with the Australian bourse.

The health, beauty, and wellness firm's securities have been on a voluntary trading halt since Sept. 4, 2024.

In the same filing, the company confirmed US-based Roquefort Therapeutics' proposed sale of Lyramid to Pleiades Pharma. It has an intellectual property license agreement with Lyramid granting it rights to receive royalties from products utilizing its midkine portfolio.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2501444008"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2501444008\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2501444008?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-01-06 05:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2501444008","market":"sg","top_or_hot":-1,"title":"Anagenics Continues Talks With ASX to Lift Trading Suspension","media":"MT Newswires Live","content":"<html><body><p> Anagenics (ASX:AN1) said it is in ongoing discussions with the Australian Securities Exchange to lift the suspension on the trading of its securities, according to a Friday filing with the Australian bourse.</p><p>The health, beauty, and wellness firm's securities have been on a voluntary trading halt since Sept. 4, 2024.</p><p>In the same filing, the company confirmed US-based Roquefort <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>' proposed sale of Lyramid to Pleiades Pharma. It has an intellectual property license agreement with Lyramid granting it rights to receive royalties from products utilizing its midkine portfolio.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Anagenics Continues Talks With ASX to Lift Trading Suspension</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnagenics Continues Talks With ASX to Lift Trading Suspension\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time smaller\">2025-01-06 05:29</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html><body><p> Anagenics (ASX:AN1) said it is in ongoing discussions with the Australian Securities Exchange to lift the suspension on the trading of its securities, according to a Friday filing with the Australian bourse.</p><p>The health, beauty, and wellness firm's securities have been on a voluntary trading halt since Sept. 4, 2024.</p><p>In the same filing, the company confirmed US-based Roquefort <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a>' proposed sale of Lyramid to Pleiades Pharma. It has an intellectual property license agreement with Lyramid granting it rights to receive royalties from products utilizing its midkine portfolio.</p></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XJO.AU","symbol_name":"標普/澳交所 200指數","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2501444008","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2501444008","pubTimestamp":1736112544,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Anagenics  said it is in ongoing discussions with the Australian Securities Exchange to lift the suspension on the trading of its securities, according to a Friday filing with the Australian bourse.The health, beauty, and wellness firm's securities have been on a voluntary trading halt since Sept. 4, 2024.In the same filing, the company confirmed US-based Roquefort Therapeutics' proposed sale of Lyramid to Pleiades Pharma. It has an intellectual property license agreement with Lyramid granting it rights to receive royalties from products utilizing its midkine portfolio.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XJO.AU":"标普/澳交所 200指数","XKO.AU":"标普/澳交所 300指数","AN1.AU":"Anagenics Ltd","BK7508":"医药生物股","XAO.AU":"标普/澳交所 普通股指数","BK7111":"个人用品"},"translate_title":"Anagenics继续与ASX谈判以解除交易暂停","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AN1.AU":0.9,"XAO.AU":0.89,"XJO.AU":0.89,"XKO.AU":0.89},"content_text":"Anagenics (ASX:AN1) said it is in ongoing discussions with the Australian Securities Exchange to lift the suspension on the trading of its securities, according to a Friday filing with the Australian bourse.The health, beauty, and wellness firm's securities have been on a voluntary trading halt since Sept. 4, 2024.In the same filing, the company confirmed US-based Roquefort Therapeutics' proposed sale of Lyramid to Pleiades Pharma. It has an intellectual property license agreement with Lyramid granting it rights to receive royalties from products utilizing its midkine portfolio.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}